Product Program year 2025 Source: CMS Open Payments

Affirm Prone Biopsy System

Device Breast and Skeletal Health

PDI 15420045504721

Open in the dashboard

General payments

$148,572

1,179 payments

Research payments

$63,560

5 payments

Through program year 2025, $148,572 in general payments and $63,560 in research payments were reported against Affirm Prone Biopsy System (Breast and Skeletal Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $77,774 123
2024 General $20,804 163
2023 General $43,380 652
2023 Research $9,660 1
2022 General $4,316 129
2022 Research $53,900 4
2021 General $2,297 112

Breakdown

Who paid General payments · program years 2021–2025
  1. Hologic, LLC $103,617 1,101 payments
  2. Hologic Inc $44,792 73 payments
  3. Bioptics, Inc. $123 3 payments
  4. Focal Therapeutics, Inc. $40 2 payments
Top recipients General payments · program year 2025
  1. Kfh - Santa Clara Teaching hospital · CA $74,165 95% · 2 payments
  2. Brian Xavier Diagnostic Radiology · Cleveland, OH $125 <1% · 1 payment
  3. Melinda Wolboldt Diagnostic Radiology · Toledo, OH $125 <1% · 1 payment
  4. Thomas Poulton Diagnostic Radiology · Canton, OH $125 <1% · 1 payment
  5. Rosalinn Santa Cruz Diagnostic Radiology · Cleveland, OH $125 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Diagnostic Radiology Radiology $1,693 49% · 33 practitioners
  2. Obstetrics & Gynecology $386 11% · 17 practitioners
  3. Family Medicine $329 9% · 22 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $200 6% · 9 practitioners
  5. Surgery $116 3% · 3 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $74,357 96% · 11 recipients
  2. Florida $737 <1% · 28 recipients
  3. Ohio $592 <1% · 7 recipients
  4. Oregon $276 <1% · 5 recipients
  5. Pennsylvania $223 <1% · 6 recipients

The top 5 of 26 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,179 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record